These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10204591)

  • 21. Therapeutic apheresis in Sweden: update of epidemiology and adverse events.
    Norda R; Stegmayr BG;
    Transfus Apher Sci; 2003 Oct; 29(2):159-66. PubMed ID: 12941356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved donor safety in high-volume apheresis collections.
    Vassallo RR; Bravo MD; Kamel H
    Transfusion; 2017 Feb; 57(2):319-324. PubMed ID: 27861957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing apheresis complications during the hematopoietic stem cell collection.
    Marlow SD; House M
    Methods Mol Biol; 2012; 904():93-6. PubMed ID: 22890925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of plasma exchange.
    Sutton DM; Nair RC; Rock G
    Transfusion; 1989 Feb; 29(2):124-7. PubMed ID: 2919422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complications with plasma exchange].
    Kimoto K; Odaka M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 2000 Oct; 40(10):1044-6. PubMed ID: 11296372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.
    Handschel D; Etienne Janssens M; Gericke M; De Reys S; Borberg H
    J Clin Apher; 2017 Oct; 32(5):319-328. PubMed ID: 27676234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.
    Tormey CA; Peddinghaus ME; Erickson M; King KE; Cushing MM; Bill J; Goodrich T; Snyder EL
    Transfusion; 2010 Feb; 50(2):471-7. PubMed ID: 19804570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serious adverse effects of blood collection].
    Danic B; Lefort C
    Transfus Clin Biol; 2010 Dec; 17(5-6):301-5. PubMed ID: 21051270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of therapeutic hemapheresis in Norway year 2000.
    Taraldsrud E; Kvalheim G; Jørstad S; Stavem K; Aandahl GS
    Transfus Apher Sci; 2003 Apr; 28(2):135-41. PubMed ID: 12679117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apheresis tolerance and acceptability in the child weighing 30 kg or less, with the exception of infants].
    Girard J; Tremisi PJ; Kassir A; Moullin T; Rigal D; Souillet G
    Transfus Clin Biol; 1996; 3(5):297-304. PubMed ID: 9004969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National survey of apheresis activity in Italy (2000).
    De Silvestro G; Marson P; Russo GE; Vicarioto M; Donadel C
    Transfus Apher Sci; 2004 Feb; 30(1):61-71. PubMed ID: 14746823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Italian registry of therapeutic apheresis - 2015.
    De Silvestro G
    Transfus Apher Sci; 2017 Feb; 56(1):75-81. PubMed ID: 28089409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of plasma-exchange.
    Belloni M; Alghisi A; Scremin L
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():180-2. PubMed ID: 8013983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange.
    Irani MS; Toushan M; Zhang L; Simpson PM; Karafin MS
    J Clin Apher; 2019 Oct; 34(5):524-527. PubMed ID: 30888726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular access practices for therapeutic apheresis: Results of a survey.
    Tanhehco YC; Zantek ND; Alsammak M; Chhibber V; Li Y; Becker J; Wu DW; Foster T; Wehrli G
    J Clin Apher; 2019 Oct; 34(5):571-578. PubMed ID: 31268582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Turkish experience with therapeutic plasma exchange: A national survey.
    Korkmaz S; Solmaz Medeni S; Demirkan F; Kalayoglu Besisik S; Altay Dadin S; Akgun Cagliyan G; Kabukcu Hacioglu S; Sari I; Goren Sahin D; Arat M; Dagdas S; Ozet G; Kutlu N; Karaagac Akyol T; Ozcebe OI; Uskudar Teke H; Kiper Unal D; Guner N; Tombak A; Celik H; Bay I; Kiki I; Ozgur G; Erkurt MA; Ozatli D; Meletli O; Demircioglu S; Demir C; Kurtoglu E; Vural F; Tobu M; Karakus A; Ayyildiz O; Dal MS; Afacan Ozturk B; Albayrak M; Ocakci S; Bolaman Z; Sonmez M; Karakus V; Gokmen Sevindik O; Berber I; Dogu MH; Gulturk E; Ulas T; Payzin B; Kuku I; Cagirgan S; Altuntas F
    Transfus Apher Sci; 2019 Jun; 58(3):287-292. PubMed ID: 31036516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic apheresis in critically ill patients.
    Sanford KW; Balogun RA
    J Clin Apher; 2011; 26(5):249-51. PubMed ID: 21834079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.